News

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Dynakin, a contract research…
Read More...

Ionis Pharmaceuticals, Inc. announced that it has entered into an exclusive licensing agreement with Bicycle Therapeutics plc to increase the delivery capabilities of Ionis' advanced …
Read More...

Biogen Inc. and InnoCare Pharma Limited announced that they have entered into a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase…
Read More...

FlowMetric Life Sciences Inc., a globally recognized life sciences company, announces the launch of VaxEffect COVID-19 Vaccine Immune Response Test, a unique and powerful platform…
Read More...

Prothena Corporation plc and Novo Nordisk A/S  announced that the companies have entered into a definitive purchase agreement under which Novo Nordisk has acquired Prothena’s clinical…
Read More...

Prime Medicine, a company delivering on the promise of Prime Editing to provide lifelong cures to patients, today announced its launch with $315 million in financing. The financing…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health…
Read More...

SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics — dissolution time. It is an innovative excipient…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in …
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive worldwide…
Read More...

I-Mab a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with…
Read More...

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for…
Read More...

INBRAIN Neuroelectronics, a company at the intersection of medtech, deeptech and digital health dedicated to developing the world’s first graphene-based intelligent neuroelectronic…
Read More...

LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including…
Read More...

Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates OXFORD, U.K. --…
Read More...

Sequanta Technologies Co., Ltd. and Mission Bio. are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using…
Read More...

SRI International (SRI) announced that the company has entered a research collaboration with Sanofi. By leveraging SRI’s SynFini platform, an artificial intelligence (AI)-guided,…
Read More...

For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral…
Read More...

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. By adding Pharmatech…
Read More...